News & Analysis on Clinical Trial Services & Contract Research And Development
A report out today cites Novartis' pipeline of drugs to continue its reputation of producing quality pharmaceuticals, with treatments for cancer, age-related macular degeneration and hypertension expected to appear within the next three years.
Scottish drug delivery and encapsulation specialist Encap has invested approximately £1.2 million (€1.7m)in new premises in order to boost its manufacturing capacity by 50 per cent.
Drug giants GlaxoSmithKline (GSK) and Galapagos have entered into a target identification collaboration identifying viable drug targets in the area of respiratory and inflammatory diseases.
Switzerland's Romaco has introduced a new laboratory scale product that provides vacuum mixing, dispersion and homogenisation and should be of particular value for formulation development in the pharmaceutical and cosmetics sectors.
Microfluidics company Nanostream has introduced a new range of cartridges designed specifically for quantitative applications such as solubility assessment and dissolution testing using its micro parallel liquid chromatography (mPLC) system.
A revolutionary new treatment for depression has been granted marketing authorisation by the European Commission. The new therapy is said to be able to treat the full spectrum of depressive symptoms.
Molecular Devices Corporation has announced the launch of the first assay kit that addresses the need for a single step, homogenous in vitro assay for fatty acid uptake for use in the identification of potential new drugs via high-throughput screening.
Researchers have uncovered a novel treatment that could prove to be effective against tuberculosis (TB), a disease that has made a comeback due to the emergence of resistant strains of the offending bacterium and the spread of AIDS.
Thermo Electron has launched a new FT-IR spectrometer specifically targeted at quality control and assurance laboratories in the pharmaceutical, chemical and polymer industries.